[Studies on the pharmacodynamics of carbochromen].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001775:Blood Circulation / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D002306:Cardiac Volume / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D003864:Depression, Chemical; D004285:Dogs; D004357:Drug Synergism; D004562:Electrocardiography; D005263:Femoral Artery; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects*; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects*; D010208:Papaverine / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery; D012119:Respiration / Q000187:drug effects*; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000633:toxicity; D014690:Venous Pressure / Q000187:drug effects*
D000889:Anti-Arrhythmia Agents; D014665:Vasodilator Agents; D010208:Papaverine; D010744:Phosphoric Monoester Hydrolases; D007545:Isoproterenol
Studien zur Pharmakodynamik des Carbochromens.